{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:22:27Z","timestamp":1792650147037,"version":"4.5.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.cyto.2021.155691","type":"journal-article","created":{"date-parts":[[2021,8,28]],"date-time":"2021-08-28T19:03:27Z","timestamp":1630177407000},"page":"155691","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Overexpression of chemokine receptor CXCR4 predicts lymph node metastatic risk in patients with melanoma: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"148","author":[{"given":"Mina","family":"Alimohammadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Rahimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Faramarzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0580-000X","authenticated-orcid":false,"given":"Reza","family":"Alizadeh-Navaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Rafiei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9460","key":"10.1016\/j.cyto.2021.155691_b0005","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(05)17951-3","article-title":"Cutaneous melanoma","volume":"365","author":"Thompson","year":"2005","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.cyto.2021.155691_b0010","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/path.2617","article-title":"Recent progress in understanding the pathology of malignant melanoma","volume":"219","author":"Kuphal","year":"2009","journal-title":"J. Pathol."},{"issue":"7","key":"10.1016\/j.cyto.2021.155691_b0015","doi-asserted-by":"crossref","first-page":"5022","DOI":"10.18632\/oncotarget.3217","article-title":"CXCR4 over-expression and survival in cancer: a system review and meta-analysis","volume":"6","author":"Zhao","year":"2015","journal-title":"Oncotarget"},{"issue":"5263","key":"10.1016\/j.cyto.2021.155691_b0020","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1126\/science.272.5263.872","article-title":"HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor","volume":"272","author":"Feng","year":"1996","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.cyto.2021.155691_b0025","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.bbamem.2006.11.002","article-title":"Regulation of CXCR4 signaling","volume":"1768","author":"Busillo","year":"2007","journal-title":"Biochim. Biophys. Acta, Biomembr."},{"issue":"6","key":"10.1016\/j.cyto.2021.155691_b0030","doi-asserted-by":"crossref","first-page":"e218","DOI":"10.1016\/S1470-2045(12)70582-X","article-title":"Cytokine patterns in patients with cancer: a systematic review","volume":"14","author":"Lippitz","year":"2013","journal-title":"Lancet Oncol."},{"issue":"2","key":"10.1016\/j.cyto.2021.155691_b0035","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.canlet.2007.05.013","article-title":"Role of chemokines in tumor growth","volume":"256","author":"Raman","year":"2007","journal-title":"Cancer Lett."},{"issue":"5","key":"10.1016\/j.cyto.2021.155691_b0040","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1158\/1078-0432.CCR-04-1195","article-title":"Effect of chemokine receptors CXCR4 and CCR7 on the metastatic behavior of human colorectal cancer","volume":"11","author":"Schimanski","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cyto.2021.155691_b0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/bcr627","article-title":"Expression pattern of CXC chemokine receptor-4 is correlated with lymph node metastasis in human invasive ductal carcinoma","volume":"5","author":"Kato","year":"2003","journal-title":"Breast Cancer Res."},{"issue":"2","key":"10.1016\/j.cyto.2021.155691_b0050","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0014-4827(03)00344-6","article-title":"Possible role of stromal-cell-derived factor-1\/CXCR4 signaling on lymph node metastasis of oral squamous cell carcinoma","volume":"290","author":"Uchida","year":"2003","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.cyto.2021.155691_b0055","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1182\/blood-2005-08-3182","article-title":"CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment","volume":"107","author":"Burger","year":"2006","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.cyto.2021.155691_b0060","doi-asserted-by":"crossref","first-page":"C987","DOI":"10.1152\/ajpcell.00406.2006","article-title":"Stroma-derived factor (SDF-1\/CXCL12) and human tumor pathogenesis","volume":"292","author":"Kryczek","year":"2007","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"8","key":"10.1016\/j.cyto.2021.155691_b0065","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s00277-003-0679-0","article-title":"CXCR4 and SDF-1 expression in B-cell chronic lymphocytic leukemia and stage of the disease","volume":"82","author":"Barretina","year":"2003","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.cyto.2021.155691_b0070","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.cell.2013.01.053","article-title":"CXCR4\/CXCL12 mediate autocrine cell-cycle progression in NF1-associated malignant peripheral nerve sheath tumors","volume":"152","author":"Mo","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.cyto.2021.155691_b0075","first-page":"1355","article-title":"Role of Twist in head and neck carcinoma with lymph node metastasis","volume":"28","author":"Ou","year":"2008","journal-title":"Anticancer Res."},{"issue":"1","key":"10.1016\/j.cyto.2021.155691_b0080","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/1479-5876-11-203","article-title":"The independent, unfavorable prognostic factors endothelin A receptor and chemokine receptor 4 have a close relationship in promoting the motility of nasopharyngeal carcinoma cells via the activation of AKT and MAPK pathways","volume":"11","author":"Luo","year":"2013","journal-title":"J. Transl. Med"},{"issue":"5","key":"10.1016\/j.cyto.2021.155691_b0085","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1267\/ahc.12004","article-title":"Chemokine receptor CXCR4 is a novel marker for the progression of cutaneous malignant melanomas","volume":"45","author":"Toyozawa","year":"2012","journal-title":"Acta Histochem. Cytochem."},{"issue":"3","key":"10.1016\/j.cyto.2021.155691_b0090","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00403-012-1222-8","article-title":"Overexpression of the chemokine receptors CXCR4, CCR7, CCR9, and CCR10 in human primary cutaneous melanoma: a potential prognostic value for CCR7 and CCR10?","volume":"304","author":"K\u00fchnelt-Leddihn","year":"2012","journal-title":"Arch. Dermatol. Res."},{"issue":"10","key":"10.1016\/j.cyto.2021.155691_b0095","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1007\/s00262-007-0303-6","article-title":"CXC chemokine receptor 4 is expressed in uveal malignant melanoma and correlates with the epithelioid-mixed cell type","volume":"56","author":"Scala","year":"2007","journal-title":"Cancer Immunol. Immunother."},{"issue":"48","key":"10.1016\/j.cyto.2021.155691_b0100","doi-asserted-by":"crossref","first-page":"45098","DOI":"10.1074\/jbc.M106912200","article-title":"Expression of functional chemokine receptors CXCR3 and CXCR4 on human melanoma cells","volume":"276","author":"Robledo","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cyto.2021.155691_b0105","first-page":"7328","article-title":"Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells","volume":"62","author":"Murakami","year":"2002","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.cyto.2021.155691_b0110","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1158\/1078-0432.CCR-04-1887","article-title":"Expression of CXCR4 predicts poor prognosis in patients with malignant melanoma","volume":"11","author":"Scala","year":"2005","journal-title":"Clinical Cancer Res."},{"issue":"5","key":"10.1016\/j.cyto.2021.155691_b0115","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/ijc.21269","article-title":"Clinical significance of CXCR3 and CXCR4 expression in primary melanoma","volume":"117","author":"Longo-Imedio","year":"2005","journal-title":"Int. J. Cancer"},{"issue":"5","key":"10.1016\/j.cyto.2021.155691_b0120","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.canep.2013.04.017","article-title":"Shen H, Liu L-x and Shu Y-q: The impact of chemokine receptor CXCR4 on breast cancer prognosis: a meta-analysis","volume":"37","author":"Xu","year":"2013","journal-title":"Cancer Epidemiol."},{"key":"10.1016\/j.cyto.2021.155691_b0125","first-page":"5163","article-title":"Chemokine receptor CXCR4 expression and lung cancer prognosis: a meta-analysis","volume":"8","author":"Liang","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"issue":"4","key":"10.1016\/j.cyto.2021.155691_b0130","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.1007\/s13277-013-1490-8","article-title":"Clinicopathological and prognostic significance of chemokine receptor CXCR4 overexpression in patients with esophageal cancer: a meta-analysis","volume":"35","author":"Wu","year":"2014","journal-title":"Tumor. Biol."},{"issue":"6","key":"10.1016\/j.cyto.2021.155691_b0135","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1080\/1354750X.2019.1637941","article-title":"CXCR4 as a prognostic biomarker in gastrointestinal cancer: a meta-analysis","volume":"24","author":"Jiang","year":"2019","journal-title":"Biomarkers"},{"key":"10.1016\/j.cyto.2021.155691_b0140","doi-asserted-by":"crossref","first-page":"5115","DOI":"10.2147\/DDDT.S82475","article-title":"The association of CXCR4 expression with clinicopathological significance and potential drug target in prostate cancer: a meta-analysis and literature review","volume":"9","author":"Chen","year":"2015","journal-title":"Drug Des Devel. Ther."},{"issue":"6","key":"10.1016\/j.cyto.2021.155691_b0145","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/annonc\/mdl053","article-title":"Expression of chemokine receptors predicts the site of metastatic relapse in patients with axillary node positive primary breast cancer","volume":"17","author":"Andre","year":"2006","journal-title":"Ann. Oncol."},{"issue":"14","key":"10.1016\/j.cyto.2021.155691_b0150","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1016\/j.ejca.2009.06.026","article-title":"CXCL12\/SDF1 expression by breast cancers is an independent prognostic marker of disease-free and overall survival","volume":"45","author":"Mirisola","year":"2009","journal-title":"Eur. J. Cancer"},{"issue":"10","key":"10.1016\/j.cyto.2021.155691_b0155","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1245\/s10434-009-0551-0","article-title":"Overexpression of CXCR4 in primary tumor of patients with HER-2 negative breast cancer was predictive of a poor disease-free survival: a validation study","volume":"16","author":"Mizell","year":"2009","journal-title":"Ann. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.cyto.2021.155691_b0160","doi-asserted-by":"crossref","first-page":"66","DOI":"10.2353\/ajpath.2009.080948","article-title":"The influence of tumor-host interactions in the stromal cell-derived factor-1\/CXCR4 ligand\/receptor axis in determining metastatic risk in breast cancer","volume":"175","author":"Hassan","year":"2009","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.cyto.2021.155691_b0165","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jss.2007.03.015","article-title":"Elevated levels of chemokine receptor CXCR4 in HER-2 negative breast cancer specimens predict recurrence","volume":"141","author":"Holm","year":"2007","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.cyto.2021.155691_b0170","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"62","author":"Liberati","year":"2009","journal-title":"J. Clin. Epidemiol."},{"issue":"2","key":"10.1016\/j.cyto.2021.155691_b0175","first-page":"119","article-title":"Novel therapeutic targets in esophageal cancer: impact of chemokine receptor CXCR4","volume":"3","author":"Gockel","year":"2007","journal-title":"Br. J. Cancer"},{"issue":"7","key":"10.1016\/j.cyto.2021.155691_b0180","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1038\/bjc.2012.49","article-title":"The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer","volume":"106","author":"Popple","year":"2012","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.cyto.2021.155691_b0185","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s10549-008-9921-8","article-title":"Elevated chemokine receptor CXCR4 expression in primary tumors following neoadjuvant chemotherapy predicts poor outcomes for patients with locally advanced breast cancer (LABC)","volume":"113","author":"Holm","year":"2009","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.cyto.2021.155691_b0190","doi-asserted-by":"crossref","first-page":"7585","DOI":"10.3748\/wjg.v12.i47.7585","article-title":"Persistent CXCR4 expression after preoperative chemoradiotherapy predicts early recurrence and poor prognosis in esophageal cancer","volume":"12","author":"Koishi","year":"2006","journal-title":"World J. Gastroenterol."},{"issue":"8","key":"10.1016\/j.cyto.2021.155691_b0195","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1245\/s10434-010-0970-y","article-title":"Stromal CXCR4 and CXCL12 expression is associated with distant recurrence and poor prognosis in rectal cancer after chemoradiotherapy","volume":"17","author":"Saigusa","year":"2010","journal-title":"Ann. Surg. Oncol."},{"issue":"6824","key":"10.1016\/j.cyto.2021.155691_b0200","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/35065016","article-title":"Involvement of chemokine receptors in breast cancer metastasis","volume":"410","author":"M\u00fcller","year":"2001","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.cyto.2021.155691_b0205","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/01.sla.0000217690.65909.9c","article-title":"Chemokine receptor CXCR4 expression in patients with melanoma and colorectal cancer liver metastases and the association with disease outcome","volume":"244","author":"Kim","year":"2006","journal-title":"Ann. Surg."},{"issue":"6","key":"10.1016\/j.cyto.2021.155691_b0210","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1111\/bjd.14720","article-title":"The prognostic significance and impact of the CXCR 4\u2013CXCR 7\u2013CXCL 12 axis in primary cutaneous melanoma","volume":"175","author":"McConnell","year":"2016","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.cyto.2021.155691_b0215","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2741\/e60","article-title":"CXCR4-CXCL12 and VEGF correlate to uveal melanoma progression","volume":"2","author":"Franco","year":"2010","journal-title":"Front Biosci. (Elite Ed.)"},{"key":"10.1016\/j.cyto.2021.155691_b0220","doi-asserted-by":"crossref","DOI":"10.3892\/ijo.25.1.65","article-title":"The clinicopathological significance of the expression of CXCR4 protein in oral squamous cell carcinoma","author":"Almofti","year":"2004","journal-title":"Int. J. Oncol."},{"issue":"12","key":"10.1016\/j.cyto.2021.155691_b0225","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1038\/labinvest.3700190","article-title":"Acquisition of lymph node, but not distant metastatic potentials, by the overexpression of CXCR4 in human oral squamous cell carcinoma","volume":"84","author":"Uchida","year":"2004","journal-title":"Lab. Invest."},{"key":"10.1016\/j.cyto.2021.155691_b0230","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1093\/jnci\/dji431","article-title":"Tumor-cell homing to lymph nodes and bone marrow and CXCR4 expression in esophageal cancer","volume":"97","author":"Kaifi","year":"2005","journal-title":"J. Natl. Cancer Inst."},{"issue":"17","key":"10.1016\/j.cyto.2021.155691_b0235","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1056\/NEJM199710233371702","article-title":"Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer","volume":"337","author":"Izbicki","year":"1997","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.cyto.2021.155691_b0240","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/jso.2930310207","article-title":"Prognostic factors of esophageal carcinoma: univariate and multivariate analyses","volume":"31","author":"Sugimachi","year":"1986","journal-title":"J. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.cyto.2021.155691_b0245","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1046\/j.1365-2133.2002.04867.x","article-title":"Metastatic pathways and time courses in the orderly progression of cutaneous melanoma","volume":"147","author":"Meier","year":"2002","journal-title":"Br. J. Dermatol."},{"issue":"4","key":"10.1016\/j.cyto.2021.155691_b0250","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.cell.2010.01.045","article-title":"Lymphangiogenesis: molecular mechanisms and future promise","volume":"140","author":"Tammela","year":"2010","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.cyto.2021.155691_b0255","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nrc2618","article-title":"Microenvironmental regulation of metastasis","volume":"9","author":"Joyce","year":"2009","journal-title":"Nat. Rev. Cancer"},{"issue":"21","key":"10.1016\/j.cyto.2021.155691_b0260","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1093\/jnci\/93.21.1638","article-title":"Wu M-t and Hwang ST: Expression of CC chemokine receptor-7 and regional lymph node metastasis of B16 murine melanoma","volume":"93","author":"Wiley","year":"2001","journal-title":"J. Natl Cancer Inst."},{"issue":"5","key":"10.1016\/j.cyto.2021.155691_b0265","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.ccr.2004.09.027","article-title":"Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis","volume":"6","author":"Li","year":"2004","journal-title":"Cancer Cell"},{"issue":"24","key":"10.1016\/j.cyto.2021.155691_b0270","doi-asserted-by":"crossref","first-page":"10411","DOI":"10.1158\/0008-5472.CAN-10-2591","article-title":"CXCR4 signaling regulates metastasis of chemoresistant melanoma cells by a lymphatic metastatic niche","volume":"70","author":"Kim","year":"2010","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.cyto.2021.155691_b0275","doi-asserted-by":"crossref","first-page":"423","DOI":"10.4161\/cbt.9.6.10996","article-title":"Histomorphologic parameters and CXCR4 mRNA and protein expression in sentinel node melanoma metastasis are correlated to clinical outcome","volume":"9","author":"Franco","year":"2010","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.cyto.2021.155691_b0280","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s10585-012-9476-2","article-title":"CCL27\u2013CCR10 and CXCL12\u2013CXCR4 chemokine ligand-receptor mRNA expression ratio: new predictive factors of tumor progression in cutaneous malignant melanoma","volume":"29","author":"Monteagudo","year":"2012","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.cyto.2021.155691_b0285","article-title":"Development of a unique small molecule modulator of CXCR4","volume":"7","author":"Liang","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.cyto.2021.155691_b0290","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1038\/bjc.2013.124","article-title":"Inhibition of CXCR4\u2013CXCL12 chemotaxis in melanoma by AMD11070","volume":"108","author":"O'Boyle","year":"2013","journal-title":"Br. J. Cancer."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466621002805?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466621002805?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T21:03:48Z","timestamp":1760907828000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466621002805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":58,"alternative-id":["S1043466621002805"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2021.155691","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Overexpression of chemokine receptor CXCR4 predicts lymph node metastatic risk in patients with melanoma: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2021.155691","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"155691"}}